Lawyers Ponder Impact of COVID Cocktail Lawsuit

October 12, 2020

Cadwalader Intellectual Property Group Chair and Partner Dorothy Auth shares her insights on the timing of Allele Biotech’s patent infringement lawsuits against Pfizer and Regeneron in connection with their use of Allele’s patented molecules to develop COVID-19 treatments. Dorothy also comments on the case’s specific issue of how research tools are used in developing pharmaceutical products.

Read the article.

CadwaladerNews

CadwaladerSpotlight

Our latest podcast covers the legacy of the “Car Wash” investigation and how Brazil fits into the global landscape of white-collar crime enforcement.

To assist individuals in working from home during the coronavirus social-distancing period, Cadwalader is providing clients and friends free access to our legal research platform, the Cadwalader Cabinet.